NATURE’S SUNSHINE PRODUCTS, INC. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $2.06M, a 82.64% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $500.00K, a 5.04% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-12-31 was $1.91M, a 315.90% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $2.02M, a 184.39% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for fiscal 2025 was $16.31M, a 84.10% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, value, acquired, cost method for fiscal 2024 was $8.86M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $2.06M 10-Q · filed 2026-08-06 | $6.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $500.00K 10-Q · filed 2026-08-06 | $16.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $16.31M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.02M 10-Q · filed 2025-11-06 | $14.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.88M 10-Q · filed 2026-08-06 | $13.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $476.00K 10-Q · filed 2026-08-06 | $7.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $8.86M 10-K · filed 2026-03-10 |
| 2024-09-30 | $711.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $5.88M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $1.85M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |